Diazepam News and Research

RSS
Diazepam is a drug used to treat mild to moderate anxiety and tension and to relax muscles. It is a type of benzodiazepine. Also called Valium.
Somnogen induces sleep in patients with primary hypersomnia

Somnogen induces sleep in patients with primary hypersomnia

Anesthetics and protein interactions: an interview with José A. Fernández

Anesthetics and protein interactions: an interview with José A. Fernández

Drugs to treat anxiety, depression and insomnia may increase risk of driving accident

Drugs to treat anxiety, depression and insomnia may increase risk of driving accident

Real-time prescription system reduces inappropriate prescribing of medications

Real-time prescription system reduces inappropriate prescribing of medications

Inappropriate prescriptions for the elderly prevalent in primary care

Inappropriate prescriptions for the elderly prevalent in primary care

SK Biopharmaceuticals receives FDA Orphan Drug status for carisbamate

SK Biopharmaceuticals receives FDA Orphan Drug status for carisbamate

SK Biopharmaceuticals initiates YKP10811 phase 2 trial in chronic constipation

SK Biopharmaceuticals initiates YKP10811 phase 2 trial in chronic constipation

Acorda's fourth quarter GAAP net income increases to $12.7 million

Acorda's fourth quarter GAAP net income increases to $12.7 million

FDA clears Neurelis IND to commence NRL-1 clinical trials for acute breakthrough seizures

FDA clears Neurelis IND to commence NRL-1 clinical trials for acute breakthrough seizures

Study unveils mechanisms behind neurological effects of penitrem A

Study unveils mechanisms behind neurological effects of penitrem A

Medications can be harmed by excessive heat

Medications can be harmed by excessive heat

New tool can effectively determine likelihood of drugs in the environment

New tool can effectively determine likelihood of drugs in the environment

Upsher-Smith initiates USL261 ARTEMIS1 Phase III study for seizure clusters in epilepsy patients

Upsher-Smith initiates USL261 ARTEMIS1 Phase III study for seizure clusters in epilepsy patients

ViroPharma receives positive European CHMP opinion for Buccolam to treat acute seizures

ViroPharma receives positive European CHMP opinion for Buccolam to treat acute seizures

Positive results from Neurelis NRL-1 Phase I pharmacokinetic study on acute repetitive seizures

Positive results from Neurelis NRL-1 Phase I pharmacokinetic study on acute repetitive seizures

Positive results from Neurelis NRL-01 Phase 1 trial against epilepsy

Positive results from Neurelis NRL-01 Phase 1 trial against epilepsy

University of Mississippi grants ChromaDex global rights to pterostilbene

University of Mississippi grants ChromaDex global rights to pterostilbene

Neurelis completes dosing in intranasal diazepam formulation study

Neurelis completes dosing in intranasal diazepam formulation study

Nanotechnology might provide greater efficacy of medicines for brain disease

Nanotechnology might provide greater efficacy of medicines for brain disease

Low-dose diazepam with NS-398 combination has twice the neuroprotective effect of NS-398 alone

Low-dose diazepam with NS-398 combination has twice the neuroprotective effect of NS-398 alone